Averitas Pharma Inc.

NJ · United States · Reporting entity ID 100001386985

Total reported 2019–2025

$6.49M

#624 of 2,960 reporting companies — 0% of all reported industry payments

$3.54M in general payments across 39,987 records, plus $2.95M in research funding across 1,139 records.

How it breaks down

General payments $3,535,521

Research funding $2,951,061

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.